We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Rituximab and Chemotherapy Followed by Ibritumomab Tiuxetan as Treatment for Low Grade Follicular Non-Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00193440
Recruitment Status : Completed
First Posted : September 19, 2005
Last Update Posted : December 30, 2010
Information provided by:
SCRI Development Innovations, LLC